Skip to content
Review Open access

Procedural Sedation in Pediatric Gastroenterology: A Narrative Review from the Shared Perspective of Pediatric Gastroenterology and Anesthesiology

Sep 2026 · Children · Vol 13 · 0 citations · 42 references
Medicine

Abstract

Highlights What are the main findings? Propofol-, ketamine-, and dexmedetomidine-based regimens dominate pediatric gastrointestinal sedation; remimazolam and esketamine are emerging, but pediatric data remain limited. Capnography detects hypoventilation before desaturation, and high-flow nasal oxygen reduces hypoxemia in adults, but pediatric evidence remains limited and not yet statistically significant. What are the implications of the main findings? Aim for the lightest effective sedation, matched to the procedure and a structured risk tier, with capnography-supported monitoring and consistent complication reporting. Because much of the pediatric evidence is extrapolated from adults, the efficacy of high-flow nasal oxygen and the role of remimazolam and esketamine require adequately powered pediatric trials before firm recommendations can be made. Abstract Background/Objectives: Endoscopic and interventional procedures in pediatric gastroenterology are increasing in number and complexity, and most require sedation or, in selected cases, general anesthesia (GA); children face a higher risk of serious sedation-related adverse events than adults. Written jointly by pediatric gastroenterologists and anesthesiologists, this review provides a practical, evidence-referenced framework for procedural sedation across pediatric gastrointestinal procedures. Methods: We performed a narrative review of PubMed/MEDLINE (inception to 20 June 2026, the date of the final search), prioritizing society guidelines, systematic reviews, randomized controlled trials, and large registries on pediatric procedural sedation, sedative agents, capnography, and high-flow nasal oxygen (HFNO). Results: Sedation should be matched to the procedure and to a structured risk tier, targeting the lightest depth that allows safe completion. Propofol-, ketamine-, and dexmedetomidine-based regimens dominate; remimazolam and esketamine are emerging, but pediatric data are limited. Capnography detects hypoventilation before desaturation, and HFNO reduces hypoxemia in adults, whereas pediatric-specific evidence remains limited and the pediatric subgroup analysis did not reach statistical significance. Higher-risk groups require tailored planning, monitoring, and rescue readiness; most evidence is observational or extrapolated from adults. Conclusions: Safe pediatric gastrointestinal sedation combines structured risk assessment, rational drug combinations, capnography-supported monitoring, and consistent complication reporting. Who administers deep sedation, and whether general anesthesia is preferred, should depend on patient and procedural risk together with local regulations, institutional policy, training and credentialing, and rescue capability, within a shared gastroenterology-anesthesiology framework. Adequately powered pediatric trials of HFNO and of remimazolam/esketamine, and long-term neurodevelopmental follow-up, are priorities.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.